Status: Not yet recruiting
Semaglutide Treatment in Type 1 Diabetes
The goal of this clinical trial is to investigate the efficacy of semaglutide on body weight, insulin dose requirements and improvements in glucose control and safety aspects in regards to risk of hypoglycemia and diabetic ketoacidosis for patients with established Type 1 Diabetes.
Participants needed: 122
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Nordsjaellands HospitalUpdated: Aug 8, 2025Locations: 1
Eligibility criteria
Type 1 Diabetes for more than 3 years [+1]
Treated with GLP1-RAs within last 6 months [+11]